NDC Compounded Drug 70004-411-56 Midazolam Hydrochloride
Injection, Solution Intravenous
Compounded Drug Product Information
NDC Crossover Products Matching Midazolam Hydrochloride
NDC crossover of Midazolam 1 Mg/ml In 0.9% Sodium Chloride with NDC 70004-411 a human compounded drug with other similar products matching the same substance name (Midazolam Hydrochloride) and the same administration route (intravenous) or dosage form (injection, solution).
NDC | Proprietary Name | Non-Proprietary Name | Package Desc | Dosage Form | Route Name | Company Name |
---|---|---|---|---|---|---|
70004-411-59 | Midazolam 1 Mg/ml In 0.9% Sodium Chloride | Midazolam 1 Mg/ml In 0.9% Sodium Chloride | 100 mL in 1 BAG | Injection, Solution | Intravenous | Sca Pharmaceuticals, Llc |
71449-130-32 | Midazolam Hydrochloride | Midazolam Hydrochloride | 5 SYRINGE, PLASTIC in 1 CONTAINER > 30 mL in 1 SYRINGE, PLASTIC | Injection, Solution | Intravenous | Denver Solutions, Llc Dba Leiters Health |
Frequently Asked Questions
What is the NDC number assigned to Midazolam Hydrochloride?
Midazolam Hydrochloride was assigned by its manufacturer with NDC product code 70004-411. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.
Which are the NDC package codes for Midazolam Hydrochloride?
The NDC package code 70004-411-56 was assigned to a 50 mL in 1 BAG of midazolam hydrochloride administered intravenous via injection, solution.
Who manufactures this product?
Midazolam Hydrochloride is manufactured by an outsourced facility and labeled by Sca Pharmaceuticals, Llc. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.
Which are the NDC crossover matchings for this product?
We found 2 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by SCA Pharmaceuticals, LLC and Denver Solutions, LLC dba Leiters Health with NDC product codes 70004-411-59 and 71449-130-32.